Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 8, 2024Nature Cardiovascular ResearchOpen Access

A bispecific antibody approach for the potential prophylactic treatment of inherited bleeding disorders

View Full Paper
Ask AI
Bookmark
Share

Authors

PGPrafull S. GandhiMŽMinka ŽivkovicPBPoul Løgstrup Bjerg

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Gandhi et al. (2024) studied this question.

synapsesocial.com/papers/68e7b3d4b6db64358770dcb3https://doi.org/10.1038/s44161-023-00418-4
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1HMB-002: A Monovalent Antibody that Elevates Circulating VWF and FVIII Levels for Treatment of Von Willebrand Disease2026 · 4 citations
  2. 2Glanzmann’s thrombasthenia: strategies for identification and management2017 · 7 citations
  3. 3A Phase 2 study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of sutacimig for prophylaxis in glanzmann thrombasthenia: A trial in progress2025
  4. 4Enhancing hemostasis in glanzmann thrombasthenia via protein S inhibition2025
  5. 5Glanzmann thrombasthenia presenting with upper gastrointestinal bleeding: a case series and review of the literature2026